Biosimilars boom: The next era of adoption

Update: 2024-09-13

Description

On this episode of the Pharmacy Insights podcast, host Scott Draeger welcomes Optum Rx SVP of Industry Relations, Jamey Millar and Optum Rx SVP of formulary management, Savitha Vivian to discuss the implications of new biosimilar alternatives to expensive biologic drugs.

Comments

In Channel

Revolutionizing pharmacy with AI and Advanced Technologies

2025-11-0617:42

Drug Pipeline Insights: Treatments Poised to Make an Impact

2025-10-1321:14

The Impact of AI on Today's Pharmacy Benefits

2025-06-2517:16

The Big Picture on Pharmacy

2025-05-0517:01

New solutions to help bend the cost curve

2025-03-1020:23

The State of Pharmacy Regulations

2024-11-1419:33

Biosimilars boom: The next era of adoption

2024-09-1317:58

Connections that count: Redefining the PBM experience

2024-04-3022:58

The New Drugs Plan Sponsors Need to Watch For

2024-02-1333:08

Preparing For the Gene Therapy Era

2023-11-0722:51

Making the Invisible Visible: Why Health Equity Matters

2023-10-0427:09

How Choice and Transparency are Changing the PBM Industry

2023-05-3118:29

The Seismic Shift in Weight Loss Medicines

2023-03-2924:13

What you can and can’t expect from biosimilars.

2022-10-2612:34

What’s happening in Specialty Pharmacy?

2022-09-1415:42

00:00

1.0x

Biosimilars boom: The next era of adoption

Savitha Vivian, Jamey Millar, Scott Draeger

#box-pro-ellipsis-176375203739983{-webkit-line-clamp:2;}Biosimilars boom: The next era of adoption

Biosimilars boom: The next era of adoption

Savitha Vivian, Jamey Millar, Scott Draeger

Biosimilars boom: The next era of adoption